Form 4 for YCBD cbdMD, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001654954-21-010812 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-10-01 | YCBD | Kennedy Thomas Ronan | CFO | M - OptEx | — | +16.7K | 24.1K | +225% | — |
| D | 2021-10-05 | 2021-10-01 | YCBD | Kennedy Thomas Ronan | CFO | A - Grant | $0.00 | +25.0K | 49.1K | +104% | $0 |
| D | 2021-10-05 | 2021-10-01 | YCBD | Kennedy Thomas Ronan | CFO | M - OptEx | $0.00 | -16.7K | 0 | -100% | $0 |
| D | 2021-10-05 | 2021-10-01 | YCBD | Kennedy Thomas Ronan | CFO | A - Grant | — | +75.0K | 75.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | M | A | 16,667 | — | 24,067 | D | — | — | (F1) Represents shares of common stock to be issued upon the vesting of restricted stock units which vest on October 1, 2021. |
| 2 | Common | Common Stock | 2021-10-01 | A | A | 25,000 | $0.00 | 49,067 | D | — | — | (F2) Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units shall vest on January 1, 2022. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2015 Equity Compensation Plan pursuant to the terms of the Executive Employment Agreement dated October 1, 2021, by and between the Issuer and the Reporting Person. |
| 3 | Derivative | Restricted Stock Unites | 2021-10-01 | M | D | 16,667 | $0.00 | 0 | D | — · — to — | 16,667 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The restricted stock units were granted on October 1, 2021 and vest on October 1, 2022. |
| 4 | Derivative | Stock Options | 2021-10-01 | A | A | 75,000 | — | 75,000 | D | $0.00 · 2021-10-01 to 2026-10-01 | 75,000 Common Stock | (F5) The stock options were granted under the 2015 Equity Compensation Plan pursuant to the terms of the Executive Employment Agreement dated October 1, 2021, by and between the Issuer and the Reporting Person. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options vest on October 1, 2022, subject to continued employment on the applicable vesting date. (F6) Not applicable. |